Skip to main content
. 2022 Apr 21;3(6):100328. doi: 10.1016/j.jtocrr.2022.100328

Figure 1.

Figure 1

Treatment-based cohort assignments. Patients were assigned to cohorts A, B, or C according to treatment with osimertinib 80 mg before CNS PD and concurrent chemotherapy or RT at the time of CNS PD. Chemo, chemotherapy; CNS, central nervous system; Osi, osimertinib; PD, disease progression; RT, radiation therapy.